USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Patent Assignment Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total properties: 11

Patent #:	8735553	Issue Dt:	05/27/2014	Application #:	14076214	Filing Dt:	11/10/2013
Title:	ANTI-PD1 ANTIBODIES AND THEIR USE AS THERAPEUTICS AND DIAGNOSTICS

Patent #:	9217034	Issue Dt:	12/22/2015	Application #:	14194797	Filing Dt:	03/02/2014
Publication #:	US20150079109	Pub Dt:	03/19/2015
Title:	ANTI-PD1 ANTIBODIES AND THEIR USE AS THERAPEUTICS AND DIAGNOSTICS

Patent #:	9834606	Issue Dt:	12/05/2017	Application #:	14736966	Filing Dt:	06/11/2015
Publication #:	US20150315274	Pub Dt:	11/05/2015
Title:	Anti-PD1 Antibodies and their Use as Therapeutics and Diagnostics

Patent #:	9988450	Issue Dt:	06/05/2018	Application #:	15802093	Filing Dt:	11/02/2017
Publication #:	US20180111995	Pub Dt:	04/26/2018
Title:	ANTI-PD1 ANTIBODIES AND THEIR USE AS THERAPEUTICS AND DIAGNOSTICS

Patent #:	10519235	Issue Dt:	12/31/2019	Application #:	15978695	Filing Dt:	05/14/2018
Publication #:	US20180251551	Pub Dt:	09/06/2018
Title:	ANTI-PD1 ANTIBODIES AND THEIR USE AS THERAPEUTICS AND DIAGNOSTICS

Patent #:	11701357	Issue Dt:	07/18/2023	Application #:	16326467	Filing Dt:	02/19/2019
Publication #:	US20210275530	Pub Dt:	09/09/2021
Title:	TREATMENT OF B CELL CANCERS USING A COMBINATION COMPRISING BTK INHIBITORS AND OBINUTUZUMAB

Patent #:	11673951	Issue Dt:	06/13/2023	Application #:	16684237	Filing Dt:	11/14/2019
Publication #:	US20200216535	Pub Dt:	07/09/2020
Title:	ANTI-PD1 ANTIBODIES AND THEIR USE AS THERAPEUTICS AND DIAGNOSTICS

Patent #:	11786529	Issue Dt:	10/17/2023	Application #:	16766803	Filing Dt:	05/26/2020
Publication #:	US20200368237	Pub Dt:	11/26/2020
Title:	TREATMENT OF INDOLENT OR AGGRESSIVE B-CELL LYMPHOMAS USING A COMBINATION COMPRISING BTK INHIBITORS

Patent #:	NONE	Issue Dt:		Application #:	17146855	Filing Dt:	01/12/2021
Publication #:	US20210130363	Pub Dt:	05/06/2021
Title:	CRYSTALLINE FORM OF (S)-7-(1-ACRYLOYLPIPERIDIN-4-YL)-2-(4-PHENOXYPHENYL)-4,5,6,7-TETRA-HYDROPYRAZOLO[1,5-a]PYRIMIDINE-3-CARBOXAMIDE, PREPARATION, AND USES THEREOF

Patent #:	11186637	Issue Dt:	11/30/2021	Application #:	17154696	Filing Dt:	01/21/2021
Publication #:	US20210230274	Pub Dt:	07/29/2021
Title:	ANTI-PD1 ANTIBODIES AND THEIR USE AS THERAPEUTICS AND DIAGNOSTICS

Patent #:	NONE	Issue Dt:		Application #:	17465975	Filing Dt:	09/03/2021
Publication #:	US20230013862	Pub Dt:	01/19/2023
Title:	SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINES AS BRUTON'S TYROSINE KINASE MODULATORS

Assignor

Exec Dt:

06/16/2021

Assignee

AESCHENGRABEN 27

BASEL, SWITZERLAND 4051

Correspondence name and address
	ELIZABETH LABARGE
	55 CAMBRIDGE PARKWAY, SUITE 700W
	CAMBRIDGE, MA 02142

Search Results as of: 05/12/2024 05:11 AM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6